CDI Laboratory Develops Promising New Antibiotic for Resistant Gonorrhea

/PRNewswire/ -- A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great...

Related Keywords

United States ,Hackensack University Medical Center ,New Jersey ,Rutgers University ,Hackensack ,Joel Freundlich ,Barry Kreiswirth ,David Perlin ,Ihor Sawczuk ,National Institutes Of Health ,World Health Organization ,Hackensack Meridian School Of Medicine ,Hackensack Meridian Center ,Translational Research ,Hackensack Meridian Health ,World Health ,National Institutes ,Clinical Integration ,Hackensack Meridian School ,Meridian Health ,World Report ,University Medical Center ,Jersey Shore University Medical Center ,Mid Atlantic Region ,